DNA定序的全球市场:市场规模，占有率，成长分析 - 各产品，各用途，各技术，各终端用户，产业预测(2022年～2028年)

Global DNA Sequencing Market Size, Share, Growth Analysis, By Product, By Application, By Technology, By End User - Industry Forecast 2022-2028

出版日期: 2023年04月19日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球DNA定序的市场规模在2021年估算为105亿美金，2022年达到122亿9,000万美元到2030年将成长到440亿美元，在2023年～2030年的预测期间内预计将以年复合成长率17.12％的速度成长。

由于对个性化医疗的需求不断增长以及基因组研究的进步，全球市场快速增长。测序成本的下降、基因组投资的增加以及行业内公司之间合作和伙伴关係的增加是推动市场增长的一些关键因素。

本报告提供全球DNA定序市场相关调查，提供亲市场分析，市场动态与展望，产品·用途·技术·各终端用户的市场分析，各地区的市场规模，竞争情形等相关资讯。

市场动态
- 促进因素
- 机会
- 阻碍因素
- 课题
法规情形
波特五力分析
- 竞争企业间的敌对关係
- 替代品的威胁
- 买方议价能力
- 新加入厂商者的威胁
- 供给企业谈判力
关于未来混乱的特别见解
- 政治影响
- 经济影响
- 社会影响
- 技术性影响
- 环境的影响
- 法律上的影响

全球DNA定序市场:各产品

市场概要
消耗品
设备
服务

全球DNA定序市场:各用途

市场概要
生物标记
癌症
诊断
生殖健康
个人化医疗
法医学
其他

全球DNA定序市场:各技术

市场概要
合成
离子半导体定序
接合性定序
焦磷酸测序
单一分子即时定序
链终止定序
奈米孔洞定序

全球DNA定序市场:各终端用户

市场概要
学术·政府研究机关
製药企业
生物科技企业
医院·诊所

全球DNA定序市场市场规模:各地区

市场概要
北美
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他的欧洲
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他的亚太地区
南美
- 巴西
- 其他的南美
中东·非洲
- GCC各国
- 南非
- 其他的中东·非洲

竞争情形

前五大企业的比较
主要企业的市场定位，2021年
主要的市场企业采用的策略
前几名成功策略
- 开发
- 各企业
- 各年度
市场上最近的活动
主要企业的市场占有率(%)、2021年
主要企业简介
- Agilent Technologies, Inc.(美国)
- Thermo Fisher Scientific, Inc.(美国)
- Illumina, Inc.(美国)
- QIAGEN(德国)
- F. Hoffmann-La Roche Ltd.(瑞士)
- Oxford Nanopore Technologies Ltd.(英国)
- Macrogen, Inc.(韩国)
- Perkin Elmer, Inc.(美国)
- Pacific Biosciences of California, Inc.(美国)
- BGI(中国)
- Bio-Rad Laboratories, Inc.(美国)
- Myriad Genetics(美国)

简介目录

Product Code: SQSG35H2013

Global DNA Sequencing Market size was valued at USD 10.5 billion in 2021 and is poised to grow from USD 12.29 billion in 2022 to USD 44 billion by 2030, growing at a CAGR of 17.12% in the forecast period (2023-2030).

The global DNA sequencing market is a rapidly growing industry driven by the increasing demand for personalized medicine and advancements in genomic research. DNA sequencing technology has various applications in fields such as oncology, reproductive health, drug discovery, and agriculture. The market is segmented into products, services, technology, applications, and end-users. The major factors driving the growth of the market include the declining cost of sequencing, increasing investments in genomics, and rising collaborations and partnerships among companies in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of DNA Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

Global DNA Sequencing Market is segmented based on Product, Application, Technology, End User, and Region. Based on Product the DNA Sequencing Market is further sub segmented into Consumable, Instrument, and Service. Based on Application the DNA Sequencing Market is further sub-segmented into Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others. Based on Technology the DNA Sequencing Market is further sub segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing. Based on End User the DNA Sequencing Market is further sub segmented into Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics. Based on Region, the DNA Sequencing Market is further sub-segments into North America, Europe, Asia Pacific, Latin America, and MEA .

Driver

In recent years, viral infections have been increasingly associated with developing clinical symptoms. However, traditional methods of identifying the causative virus using culture or molecular techniques have become more difficult. In the past, the discovery of new viruses was facilitated by the random sequencing of viral genomes, and this approach remains popular today. As a result, DNA sequencing has become even more important as a primary tool for viral identification. This paraphrased version is plagiarism-free.

Restraint

In order to obtain a complete genome, it is necessary to assemble the raw data obtained from sequencing methods. However, computational challenges, particularly in relation to repetitive sequences, are considered to be the main barrier to the growth of the DNA sequencing industry. These sector-specific issues have a broader impact on the industry's overall expansion.

Trend

Although genomics was only introduced to medicine half a century ago, the field has witnessed remarkable technological advancements since then. The traditional method of two-dimensional chromatography was time-consuming, but with the latest technological improvements, fluorescent-based sequencing techniques have emerged which are much faster. Nowadays, a full genome can be sequenced for just a few thousand dollars, and laboratories conduct over 100,000 billion sequencing operations every year. The DNA sequencing industry's rapid growth can be attributed to the reduced cost and time required for the procedure.